Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve')

B Tehan¹, R Hardern, A Bodenham

¹Leeds General Infirmary.

|June 1, 1993

Summary

A patient presented with severe symptoms including hyperthermia and muscle rigidity. Toxicology confirmed 3,4-methylenedioxyethamphetamine (MDEA, "Eve") exposure, not MDMA ("Ecstasy"), and malignant hyperthermia testing was negative.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Central venous access by the subclavian vein - what is best practice?

Anaesthesia·2021

Same author

pRotective vEntilation with veno-venouS lung assisT in respiratory failure: A protocol for a multicentre randomised controlled trial of extracorporeal carbon dioxide removal in patients with acute hypoxaemic respiratory failure.

Journal of the Intensive Care Society·2017

Same author

Vascular access after axillary lymph node surgery - a reply.

Anaesthesia·2016

Same author

A multicentre snapshot study of the incidence of serious procedural complications secondary to central venous catheterisation.

Anaesthesia·2016

Same author

AAGBI safe vascular access guidelines - a reply.

Anaesthesia·2016

Same author

Ultrasound guided infraclavicular axillary vein cannulation, coming of age.

British journal of anaesthesia·2016

Area of Science:

Toxicology
Pharmacology
Emergency Medicine

Background:

The patient exhibited symptoms consistent with a severe adverse drug reaction, including hyperthermia, muscle rigidity, rhabdomyolysis, and disseminated intravascular coagulation.
Initial assessment suggested 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") as the causative agent.
Distinguishing between structurally similar substances is critical in clinical toxicology.